Ethaselen (BBSKE) is an orally active and selective thioredoxin reductase 1 (TrxR) inhibitor with anticancer activity that directly inhibits TrxR1 activity and is commonly used in combination with oxaliplatin to inhibit tumor growth.Ethaselen induces apoptosis in cancer cells and inhibits the proliferation of colorectal cancer cells.
Molekulargewicht:
422.2
Reinheit:
97.58%
CAS Nummer:
[217798-39-5]
Formel:
C16H12N2O2Se2
Target-Kategorie:
Reductase
T39664
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten